No open-market buys or sells in this period. The transactions below are grants, option exercises and gifts, which carry no market price.
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
No open-market buys or sells in this period — showing all activity (grants, exercises & gifts).
-
BHC Other·F
EVP, US Pharma
$106.2K
17.6K sh · $6.04
Own -4%
-
BHC Grant·A
EVP, US Pharma
$0
157.1K sh
Own +60%
-
BHC Grant·A
EVP, US Pharma
$0
30.8K sh
Own +13%
-
BHC Other·F
EVP, US Pharma
$146.0K
22.7K sh · $6.42
Own -9%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Feb 26, 2026 | BHC | Other F | 17.6K | $106.2K |
| Feb 25, 2026 | BHC | Grant A | 157.1K | $0 |
| Jul 17, 2025 | BHC | Grant A | 30.8K | $0 |
| Jul 15, 2025 | BHC | Other F | 22.7K | $146.0K |
Buy Sell Non-market (grant · exercise · gift)
About Lenar Aimee J.
This profile aggregates every SEC Form 4 insider transaction reported by Lenar Aimee J. across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.